Compounds > pyrrolomycin d
Page last updated: 2024-09-04

pyrrolomycin d and tazobactam

pyrrolomycin d has been researched along with tazobactam in 1 studies

Compound Research Comparison

Studies
(pyrrolomycin d)		Trials
(pyrrolomycin d)		Recent Studies (post-2010)
(pyrrolomycin d)		Studies
(tazobactam)		Trials
(tazobactam)		Recent Studies (post-2010) (tazobactam)
6021,327153694

Protein Interaction Comparison

ProteinTaxonomypyrrolomycin d (IC50)tazobactam (IC50)
Beta-lactamase Klebsiella pneumoniae0.08
Beta-lactamase Escherichia coli0.01
Beta-lactamase Citrobacter freundii0.096
Beta-lactamase Citrobacter gillenii0.04
Beta-lactamase Shouchella clausii0.004
Beta-lactamase Burkholderia cenocepacia0.5
Beta-lactamase Pseudomonas aeruginosa0.06
Beta-lactamase Pseudomonas aeruginosa2
B2 bradykinin receptorCavia porcellus (domestic guinea pig)4.8
Beta-lactamaseStaphylococcus aureus0.5
Beta-lactamaseBacillus licheniformis0.51
Beta-lactamaseEscherichia coli K-120.25
Beta-lactamaseCitrobacter freundii0.93
Beta-lactamaseEnterobacter cloacae1.3748
Beta-lactamase SHV-1Escherichia coli0.222
Beta-lactamase SHV-1Klebsiella pneumoniae0.11
Beta-lactamase OXA-1Escherichia coli4.8
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.83
Cytochrome P450 2B6Homo sapiens (human)0.11
Beta-lactamasePseudomonas aeruginosa PAO12.51
Beta-lactamase TEMEscherichia coli0.0828
Beta-lactamaseMorganella morganii0.19
Beta-lactamase Salmonella enterica subsp. enterica serovar Westhampton0.0022
Beta-lactamase Pseudomonas aeruginosa2
Beta-lactamase Enterobacter cloacae0.03
Class D beta-lactamaseBrachyspira pilosicoli0.16
Beta-lactamase Pseudomonas luteola0.04
Beta-lactamase Escherichia coli0.24
Beta-lactamase Serratia fonticola6.9
Beta-lactamase Enterobacter cloacae0.06
Beta-lactamase Escherichia coli0.002
Carbapenem-hydrolyzing beta-lactamase KPCKlebsiella pneumoniae0.372

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barraja, P; Carbone, A; Cascioferro, S; Cirrincione, G; Diana, P; Montalbano, A; Parrino, B; Schillaci, D; Spanò, V1

Other Studies

1 other study(ies) available for pyrrolomycin d and tazobactam

ArticleYear
Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms.
    Journal of medicinal chemistry, 2017, 10-26, Volume: 60, Issue:20

    Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Imipenem; Pseudomonas Infections

2017